ArticleScientific reports2023

Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer.

Buze Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.